Q2 2022 Inovio Pharmaceuticals Inc Earnings Call Transcript
Good afternoon, and welcome to the INOVIO Pharmaceuticals conference call.
(Operator Instructions) Please note, this event is being recorded.
I would now like to turn the conference over to Thomas Hong, Manager of Investor Relations. Please go ahead.
Good afternoon, and thank you for joining the INOVIO Second Quarter 2022 Financial Results Conference Call. Joining me today on today's call are Dr. Jacqui Shea, President and CEO; Mr. Peter Kies, Chief Financial Officer; Dr. Michael Sumner, Chief Medical Officer; Dr. Laurent Humeau, Chief Scientific Officer; Dr. David Liebowitz, Senior Vice President of Clinical Development for Infectious Diseases; and Dr. Jeffrey Skolnik, Senior Vice President of Clinical Development for Immuno-Oncology and HPV Therapeutics.
Today's call will review our corporate and financial information for the quarter ended June 30, 2022, as well as provide an update on our efforts to develop our DNA medicines platform. Following prepared remarks, we will conduct a question-and-answer segment.
During
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |